Trinity Biotech Files 6-K for August Reporting

Ticker: TRIB · Form: 6-K · Filed: Aug 7, 2024 · CIK: 888721

Trinity Biotech PLC 6-K Filing Summary
FieldDetail
CompanyTrinity Biotech PLC (TRIB)
Form Type6-K
Filed DateAug 7, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: reporting, regulatory-filing, foreign-private-issuer

TL;DR

Trinity Biotech filed a 6-K on Aug 7, confirming August reporting and 20-F annual filings.

AI Summary

Trinity Biotech plc filed a Form 6-K on August 7, 2024, to report information as a foreign private issuer. The filing indicates the company is submitting its report for the month of August 2024 and will file its annual reports under cover of Form 20-F. The company's principal executive office is located in Bray, County Wicklow, Ireland.

Why It Matters

This filing serves as a routine update for investors and regulatory bodies, confirming Trinity Biotech's ongoing compliance and reporting schedule as a foreign private issuer.

Risk Assessment

Risk Level: low — This is a routine administrative filing and does not contain new financial or operational information that would typically impact risk.

Key Players & Entities

  • TRINITY BIOTECH PLC (company) — Registrant
  • August 7, 2024 (date) — Filing Date
  • Form 6-K (document) — Filing Type
  • Form 20-F (document) — Annual Report Cover
  • Bray, County Wicklow, Ireland (location) — Principal Executive Office Address

FAQ

What is the purpose of this Form 6-K filing?

The purpose of this Form 6-K is to report information as a foreign private issuer for the month of August 2024.

When was this Form 6-K filed?

This Form 6-K was filed on August 7, 2024.

Under which form will Trinity Biotech plc file its annual reports?

Trinity Biotech plc will file its annual reports under cover of Form 20-F.

Where is Trinity Biotech plc's principal executive office located?

Trinity Biotech plc's principal executive office is located at IDA Business Park, Bray, County Wicklow, Ireland.

Is Trinity Biotech plc submitting this Form 6-K in paper format?

The filing does not explicitly state if it is being submitted in paper format, but it includes checkboxes for Regulation S-T Rule 101(b)(1) and 101(b)(7) which are related to paper submissions.

Filing Stats: 319 words · 1 min read · ~1 pages · Grade level 13.2 · Accepted 2024-08-07 17:26:45

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TRINITY BIOTECH PLC Trinity Biotech plc (Registrant) By: /s/ John Gillard John Gillard Chief Executive Officer Date: August 7, 2024

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.